This is an RSS newsfeed from BioMed Central It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit http://www.biomedcentral.com/info/about/rss/ Current Opinion in Molecular Therapeutics - Latest articles http://thomsoncurrentdrugs.com/products/journals/comt The latest articles from Current Opinion in Molecular Therapeutics (ISSN 1464-8431) published by Current Drugs Limited. Sitimagene ceradenovec, a gene therapeutic for the treatment of glioma http://www.biomedcentral.com/1464-8431/10/187 N Düzgünes Current Opinion in Molecular Therapeutics 2008, 10:187-195 2008-03-31 doi:10.1186/cd-891057 Current Opinion in Molecular Therapeutics 1464-8431 10 187 2008-03-31 VB4-845: A conjugated recombinant antibody and immunotoxin for head and neck cancer and bladder cancer http://www.biomedcentral.com/1464-8431/10/176 K Biggers and N Scheinfeld Current Opinion in Molecular Therapeutics 2008, 10:176-186 2008-03-31 doi:10.1186/cd-891056 Current Opinion in Molecular Therapeutics 1464-8431 10 176 2008-03-31 Sugar boost: When ribose modifications improve oligonucleotide performance http://www.biomedcentral.com/1464-8431/10/168 M Faria and H Ulrich Current Opinion in Molecular Therapeutics 2008, 10:168-175 2008-03-31 doi:10.1186/cd-891054 Current Opinion in Molecular Therapeutics 1464-8431 10 168 2008-03-31 RNAi therapeutics: An update on delivery http://www.biomedcentral.com/1464-8431/10/158 T Nguyen, EM Menocal, J Harborth and JH Fruehauf Current Opinion in Molecular Therapeutics 2008, 10:158-167 2008-03-31 doi:10.1186/cd-891052 Current Opinion in Molecular Therapeutics 1464-8431 10 158 2008-03-31 Emerging role of microRNAs in disease pathogenesis and strategies for therapeutic modulation http://www.biomedcentral.com/1464-8431/10/150 J Mattes, A Collison and PS Foster Current Opinion in Molecular Therapeutics 2008, 10:150-157 2008-03-31 doi:10.1186/cd-891050 Current Opinion in Molecular Therapeutics 1464-8431 10 150 2008-03-31 The therapeutic potential of antisense-mediated exon skipping http://www.biomedcentral.com/1464-8431/10/140 Ommen G-J van, Deutekom J van and A Aartsma-Rus Current Opinion in Molecular Therapeutics 2008, 10:140-149 2008-03-31 doi:10.1186/cd-891048 Current Opinion in Molecular Therapeutics 1464-8431 10 140 2008-03-31 Multifunctional peptide-based nanosystems for improving delivery and molecular imaging http://www.biomedcentral.com/1464-8431/10/132 DF Emerich and CG Thanos Current Opinion in Molecular Therapeutics 2008, 10:132-139 2008-03-31 doi:10.1186/cd-891046 Current Opinion in Molecular Therapeutics 1464-8431 10 132 2008-03-31 EGFR-targeted therapy in colorectal cancer: Does immunohistochemistry deserve a role in predicting the response to cetuximab? http://www.biomedcentral.com/1464-8431/10/124 AM Valentini, M Pirrelli and ML Caruso Current Opinion in Molecular Therapeutics 2008, 10:124-131 2008-03-31 doi:10.1186/cd-891041 Current Opinion in Molecular Therapeutics 1464-8431 10 124 2008-03-31 Membrane proteins as diagnostic biomarkers and targets for new therapies http://www.biomedcentral.com/1464-8431/10/116 D Josic, JG Clifton, S Kovac and DC Hixson Current Opinion in Molecular Therapeutics 2008, 10:116-123 2008-03-31 doi:10.1186/cd-891039 Current Opinion in Molecular Therapeutics 1464-8431 10 116 2008-03-31 Identifying autoantigens as theranostic targets: Antigen arrays and immunoproteomics approaches http://www.biomedcentral.com/1464-8431/10/107 OW Tassinari, RJ Jr Caiazzo, JR Ehrlich and BC-S Liu Current Opinion in Molecular Therapeutics 2008, 10:107-115 2008-03-31 doi:10.1186/cd-891036 Current Opinion in Molecular Therapeutics 1464-8431 10 107 2008-03-31 A fight at the opera http://www.biomedcentral.com/1464-8431/10/105 J Goodchild Current Opinion in Molecular Therapeutics 2008, 10:105-106 2008-03-31 doi:10.1186/cd-891034 Current Opinion in Molecular Therapeutics 1464-8431 10 105 2008-03-31 Web alert http://www.biomedcentral.com/1464-8431/10/103 AC Stephens Current Opinion in Molecular Therapeutics 2008, 10:103-104 2008-03-31 doi:10.1186/cd-891033 Current Opinion in Molecular Therapeutics 1464-8431 10 103 2008-03-31 Patent alert http://www.biomedcentral.com/1464-8431/10/99 Scientific Current Awareness Thomson Current Opinion in Molecular Therapeutics 2008, 10:99-102 2008-03-31 doi:10.1186/cd-891030 Current Opinion in Molecular Therapeutics 1464-8431 10 99 2008-03-31 Paper alert http://www.biomedcentral.com/1464-8431/10/95 RE Hurst Current Opinion in Molecular Therapeutics 2008, 10:95-98 2008-03-31 doi:10.1186/cd-891021 Current Opinion in Molecular Therapeutics 1464-8431 10 95 2008-03-31 Myodys, a full-length dystrophin plasmid vector for Duchenne and Becker muscular dystrophy gene therapy http://www.biomedcentral.com/1464-8431/10/86 D Duan Current Opinion in Molecular Therapeutics 2008, 10:86-94 2008-01-25 doi:10.1186/cd-870652 Current Opinion in Molecular Therapeutics 1464-8431 10 86 2008-01-25